| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/24/2007 | EP1745778A2 Diaminoalcohols as therapeutic compounds |
| 01/24/2007 | EP1745777A1 Amido-aminoalcohols as therapeutic compounds |
| 01/24/2007 | EP1745776A1 Aminoalcohols as therapeutic compounds |
| 01/24/2007 | EP1745774A2 Solid pharmaceutical dispersions with enhanced bioavailability |
| 01/24/2007 | EP1745295A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 01/24/2007 | EP1745060A2 Compounds for treating alzheimer's disease and for inhibiting beta-amyloid peptide production |
| 01/24/2007 | EP1745047A1 Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine adenosine-a2a- receptor antagonists |
| 01/24/2007 | EP1745046A2 1 h-indazoles, benzothiazoles, 1,2-benziosoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
| 01/24/2007 | EP1745042A1 Diarylamine derivatives as calcium channel blockers |
| 01/24/2007 | EP1745040A1 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors |
| 01/24/2007 | EP1745031A1 Crystalline forms of duloxetine free base |
| 01/24/2007 | EP1745029A1 Substituted morpholine compounds for the treatment of central nervous system disorders |
| 01/24/2007 | EP1745010A1 Substituted cyclohexyl-1,4-diamine derivatives |
| 01/24/2007 | EP1744751A2 Methods for the treatment of synucleinopathies |
| 01/24/2007 | EP1744729A2 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| 01/24/2007 | EP1481007B1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, treatments and animal models produced therefrom |
| 01/24/2007 | EP1461070B1 Combined use of a glp-1 compound and an aldose reductase inhibitor |
| 01/24/2007 | EP1408964B1 Use of 2- 5-(4-fluorophenyl)-3-pyridylmethylaminomethyl|-chromane and its physiologically acceptable salts |
| 01/24/2007 | EP1377555B1 A dioxino[2,3-g]quinoline-9-carboxylic acid derivative as nk3 receptor antagonist |
| 01/24/2007 | EP1180028B1 Il-8 receptor antagonists |
| 01/24/2007 | EP1123414B1 Antisense modulation of integrin alpha 4 expression |
| 01/24/2007 | EP1100507B1 Use of a combination comprising a precursor of uric acid and antioxidant for the treatment of neurodegenerative deseases |
| 01/24/2007 | EP0970213B1 Death domain containing receptor 5 |
| 01/24/2007 | EP0968206B8 N-heterocyclic derivatives as nos inhibitors |
| 01/24/2007 | EP0951536B1 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them |
| 01/24/2007 | EP0941341B1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 01/24/2007 | CN1902206A Preparation of 1-aza-2-oxa-dibenzo [e,h] azulenes and their use for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 01/24/2007 | CN1902204A 烟碱性乙酰胆碱受体配体 Nicotinic acetylcholine receptor ligands |
| 01/24/2007 | CN1902203A Diaza-spiropiperidine derivatives as inhibitors of glycine transporter 1 and glycine transporter 2 |
| 01/24/2007 | CN1902201A Bicyclic pyrimidin-4-(3H)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (VR1) |
| 01/24/2007 | CN1902182A Macrocyclic lactams and pharmaceutical use thereof |
| 01/24/2007 | CN1902178A Therapeutic agents useful for treating pain |
| 01/24/2007 | CN1902177A Novel piperidine derivative |
| 01/24/2007 | CN1901928A Migraine remedy |
| 01/24/2007 | CN1901918A Use of 3-aza-1-oxa-dibenzo [e,h] azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 01/24/2007 | CN1901913A Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
| 01/24/2007 | CN1901904A Use of 1,2-diaza-dibenzo[e,h]azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 01/24/2007 | CN1901898A Treatment of neurodegenerative disease |
| 01/24/2007 | CN1900076A Tetrahydro proto-berberine compounds, and their preparing method and use |
| 01/24/2007 | CN1900075A Tetrahydro-proto-berberine compounds, their preparing method, composition and use |
| 01/24/2007 | CN1900074A Substituted oxazolidinones and their use in the field of blood coagulation |
| 01/24/2007 | CN1900067A Tricyclic compounds, their production and use |
| 01/24/2007 | CN1899602A RanBPM important function in nervous system |
| 01/24/2007 | CN1899508A Chinese medicine for strengthening spleen, tonifying kidney and nourshing heart to calm mind and its preparing method |
| 01/24/2007 | CN1899470A Process for preparing Chinese medicine soft capsule for treating body weak hypodynamia and insomnia |
| 01/24/2007 | CN1899428A Chinese medicine preparation for treating pain and its preparing method |
| 01/24/2007 | CN1899427A Chinese medicine composition with blood pressure reducing and tranquilizing function and its preparing method |
| 01/24/2007 | CN1899417A Chinese herbal medicine liquid for treating waist and leg pain |
| 01/24/2007 | CN1899405A Mouth spray liquid for giving-up smoking and its preparing method |
| 01/24/2007 | CN1899396A External application medicinal bag for treating waist and leg pain and producing method |
| 01/24/2007 | CN1899335A Angong niuhuang soft capsule and its preparing method |
| 01/24/2007 | CN1899307A Deporteinnized calf serum injection and its preparing method |
| 01/24/2007 | CN1899303A Medicine composition, plaster and soft paste with analgesic function |
| 01/24/2007 | CN1899288A Quetiapine granules |
| 01/24/2007 | CN1899287A Slow release medicinal composition for treating anxiety and its preparing method |
| 01/24/2007 | CN1899278A Theanine used for preparing medicine/health product for treating depression |
| 01/24/2007 | CN1899270A Medical super fire micro capsule capsaicine and its preparing method |
| 01/24/2007 | CN1296386C Use of CD 25 binding molecules in steroid-resistant patients |
| 01/24/2007 | CN1296380C Pharmaceutical compound |
| 01/24/2007 | CN1296368C Benzothiophenes as adenosine receptor regulating agent |
| 01/24/2007 | CN1296365C Imidazolinylmethyl aralkylsulfonamides |
| 01/24/2007 | CN1296361C Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 01/24/2007 | CN1296354C Pharmaceutically active pyrrolidine derivatives as BAX inhibitors |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/24/2007 | CN1296068C Preparing and quality controlling method of Chinese traditional medicine composition |
| 01/24/2007 | CN1296052C Non-injection preparation containing medium and/or low molecular weight chondroitin sulfate |
| 01/24/2007 | CN1296045C Dihydroergotoxine and its derivative oral disintegration tablet and its preparing process |
| 01/24/2007 | CN1296039C Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 01/24/2007 | CN1296037C Whole gastrodia tuber dripping pills and its preparing process |
| 01/23/2007 | US7166761 Detecting and monitoring adjustments in proteoglycan type receptor type protein tyrosine phosphatase (PTP) activity; enznyme inhibitors; diagnosing and treating gastrointestinal disorders |
| 01/23/2007 | US7166729 Process for the preparation of 5-substituted isobenzofurans |
| 01/23/2007 | US7166726 Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 01/23/2007 | US7166723 5-hydroxy- or 1-glyceryl-substituted quinolines, isoquinolines or cinnolines as chemical intermediates |
| 01/23/2007 | US7166642 Use of cyclohexenone long-chain alcohol for treating neurodegenerative diseases |
| 01/23/2007 | US7166639 Blocking activation of transcription factor; aminothiophene compound; tissue repair; antiarthritic agents; inflammatory bowel disorders; antihistamines;; osteoporosis; skin disorders; autoimmune diseases |
| 01/23/2007 | US7166632 such as (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C); for treatment of obesity |
| 01/23/2007 | US7166631 E-series of prostaglandin (EP) receptors; e.g [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 01/23/2007 | US7166630 contains 4-[ alpha -hydroxy-5-(1-imidazolyl)-2-methylbenzyl]-3,5-dimethylbenzoic acid; prophylaxis, hypomyelination, dysmyelination or demyelination; myelin-associated glycoprotein (MAG) |
| 01/23/2007 | US7166629 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 01/23/2007 | US7166625 Method for treating fibrotic diseases and other indications |
| 01/23/2007 | US7166623 Pain and inflammation |
| 01/23/2007 | US7166622 Administering substituted phenylsulfonamide for therapy and prophylaxis of Alzheimer's Disease and Down's syndrome |
| 01/23/2007 | US7166618 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 01/23/2007 | US7166617 Cyclic amide derivatives |
| 01/23/2007 | US7166613 Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands |
| 01/23/2007 | US7166610 Method of treating movement disorders using barbituric acid derivatives |
| 01/23/2007 | US7166608 for use with various disorders including sleep disorders; depression; cardiovascular disorders; pain; neurodegenerative disorders; psychiatric disorders etc. |
| 01/23/2007 | US7166605 Prophylaxis; endothelial diseases, oxidative stress, cardiovascular, inflammatory, cardiovascular, ocular, autoimmune diseases, neurological disorders and cancer, hypercholesterolemia and hyperlipidemia |
| 01/23/2007 | US7166598 Piperazine derivatives |
| 01/23/2007 | US7166597 Antiinflammatory agents; autoimmune disease treatments; pyrazolo(1,5-a)pyridine derivatives |
| 01/23/2007 | US7166593 Glucocorticoid receptor modulators |
| 01/23/2007 | US7166592 Antiinflammatory agents |
| 01/23/2007 | US7166588 Derivatives and analogs of galanthamine |
| 01/23/2007 | US7166587 Gamma -secretase inhibitors; for treatment of Alzheimer's disease; e.g 2,3-difluoro-benzyl)-carbamic acid (S)-1-(5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-ylcarbamoyl)-ethyl ester |
| 01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
| 01/23/2007 | US7166579 inhibitors of dipeptidyl peptidase; treatment of impaired glucose tolerance, glucosuria, hyperlipidaemia, metabolic acidoses, diabetes mellitus, diabetic neuropathy and nephropathy and of sequelae of diabetes mellitus in mammals |
| 01/23/2007 | US7166467 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 01/23/2007 | US7166311 Process for producing fat composition containing hydrophobic components of glycyrrhiza |
| 01/23/2007 | US7166285 Anti-IL-12 antibodies and compositions |
| 01/23/2007 | US7166279 Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities |